| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8485738 | Vaccine | 2018 | 7 Pages |
Abstract
Increasing MuCV coverage achieved declining mumps incidence and complication rate. Current epidemiology supported 2-dose MuCV vaccination policy. The incidence rise in persons aged 15-19â¯years in 2012 and waning immunity for the 2nd MuCV dose merited close follow-up.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Rui Ma, Li Lu, Tao Zhou, Jingbin Pan, Meng Chen, Xinghuo Pang,